Trials / Completed
CompletedNCT05936502
Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer
Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer Part of the Evaluation Prognostic and Predictive Indicators in Head and Neck Cancer (EPIC) Programme, Run Under the Auspices of the Head and Neck Inter Group (HNCIG, Www.Hncig.Org)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,500 (actual)
- Sponsor
- Head and Neck Cancer International Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Extranodal extension (ENE) refers to the spread of head and neck squamous cell carcinoma (HNSCC) outside the lymph nodes. It is a well-known factor that indicates a poorer prognosis and outcome for patients who have undergone surgical removal of the cancer. In such cases, it is recommended to combine chemotherapy with radiation therapy after surgery. As the number of cases of HNSCC related to the human papillomavirus (HPV) is increasing, treatment approaches have shifted towards using radiation therapy as the primary treatment method instead of surgery. This raises an important question about the significance of ENE observed through imaging tests (referred to as iENE) and its impact on the prognosis. Unfortunately, this question remains unanswered. The objective of this project is to conduct a comprehensive study across multiple medical institutions. The investigators will gather data including scan results, histopathology reports, and data from patient charts from individuals who have been treated for head and neck cancer. The aim is to analyze and correlate the findings between the pathological evidence of ENE and the imaging results, while also assessing the prognostic value of iENE. Additionally, the investigators will explore the influence of HPV status on these factors. By collecting and analyzing this data, the investigators hope to establish standardized criteria that can assist radiologists in accurately identifying ENE through imaging tests. This research is essential for enhancing our understanding of HNSCC and improving the effectiveness of diagnostic procedures and treatment planning.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extranodal extension | Extranodal extension presence or absence on radiology and pathology assessment |
Timeline
- Start date
- 2022-07-11
- Primary completion
- 2023-08-15
- Completion
- 2023-09-30
- First posted
- 2023-07-07
- Last updated
- 2024-02-01
Locations
12 sites across 8 countries: United States, Australia, Denmark, France, Germany, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT05936502. Inclusion in this directory is not an endorsement.